Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study on the Effects of Postnatal Enalapril on Maternal Cardiovascular Function Following Preterm Pre-eclampsia.

NCT03466333 is registered in ClinicalTrials.gov with Manchester University NHS Foundation Trust as lead sponsor.

NCT NCT03466333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03466333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study on the Effects of Postnatal Enalapril on Maternal Cardiovascular Function Following Preterm Pre-eclampsia.
Lead sponsor
Manchester University NHS Foundation Trust
Phase
Phase 2
Overall status
Completed
Start date
September 5, 2018
Completion date
September 11, 2020
Enrollment
118 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, pre-eclampsia onset less than 37 weeks (diagnosis)